Life is our mission.


Resuscitec GmbH is a medical technology company. We develop and distribute intelligent products for emergency medicine. With our activities we enable the restoration of patients’ health and thus make a sustainable contribution to improving their quality of life.

To this end, we have developed and approved the world’s first mobile system for controlled, targeted and personalized restoration of circulation outside the hospital.

We want to make a substantial contribution to saving lives with our products. The task of providing physicians, perfusionists and qualified specialists with an efficient tool for controlled, personalized whole-body reperfusion is therefore our company’s top priority.

Opening a new chapter in the history of resuscitation.


The history of our company represents the successful implementation ­of a therapeutic vision.


Founding of the company as a spin-off of Freiburg University Hospital on the initiative of Univ.-Prof. Dr. Dr. h. c. Friedhelm Beyersdorf, Former Medical Director of the Clinic of Cardiovascular Surgery at The Medical Center – University of Freiburg


Development and optimization of the CARL Therapy through application in large animal model, development and optimization of the CARL System


Certification of the company according to EN ISO 13485


Clinical proof of concept in the context of an application observation at the The Medical Center – University of Freiburg


Participation in the EU program “Horizon 2020, Fast Track to Innovation Pilot” for the project CIRDinnova. This project has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 730527.


The company is awarded the Freiburg Innovation Prize


Move to larger company premises in the BioTechPark Freiburg


CE approval of the CARL System and start of the Post Market Clinical Follow-Up Study (PMCF) at four European centers


Launch of the new brand identity

Establishment of the CARL Academy

Start of the FDA approval process and preparation for the US market entry


Sales launch for the CARL System in Europe

Start of production and scale-up

Changeover to MDR

Winning of the GDA and IF awards

United for saving human lives.


Erich R. Reinhardt
Chairman of the Advisory Board

Thomas Kraft
Managing Director (CEO)

Christoph Benk
Managing Director (CTO)

Jörg Alexander Ronde
Managing Director (CFO)

Every life is unique, and every person is different.


The development of the CARL System from the first draft to market maturity was and is closely linked to the personal competence, enthusiasm and cooperativeness of our founders and employees. We are particularly proud of the professional and personal skills of our employees and work to maintain the high quality of interdisciplinary cooperation in our company. To this end, it is necessary to assess the respective competencies and skills precisely and to link them in the interest of all involved without restricting the subjective scope of action too much.

What applies to the patient-specific use of the CARL System therefore also applies to the working conditions in our company: We offer our employees, students and trainees flexible career and training opportunities with working hours adapted to the situation, performance-related remuneration and numerous promotion opportunities.

As a future-oriented company, we also attach particular importance to a collegial and appreciative working environment in which a dynamically motivated team focuses not only on the economic goals of our company, but above all on the well-being, safety and quality standards of the people who are to benefit from our work. The following aspects of our corporate culture should contribute to this: respect, reliability and quality assurance.


Interested in a smart working environment?


Interested? Then find out about our current vacancies, bachelor’s/master’s theses and internships and apply at

We are looking forward to hearing from you!